almitrine--raubasine-drug-combination has been researched along with Brain-Diseases* in 1 studies
1 trial(s) available for almitrine--raubasine-drug-combination and Brain-Diseases
| Article | Year |
|---|---|
[Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
In a double-blind cross-over study, the effects of Duxil on blood gases at rest were compared to those of a placebo in 39 elderly patients (mean age: 74.8 years). The study lasted 6 months divided into two 3-month periods. A mean increase of 2.10 mmHg in PaO2 was observed in patients under Duxil, the difference with the results obtained under placebo being statistically significant (p less than 0.01). At that dosage level, Duxil may therefore be considered an active treatment of hypoxia associated with old age. Topics: Aged; Almitrine; Brain Diseases; Dementia; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen; Partial Pressure; Piperazines; Time Factors; Yohimbine | 1983 |